Vanda Pharmaceuticals Inc (VNDA)

NASDAQ
Currency in USD
Disclaimer
3.56
0.00(0.00%)
Closed
After Hours
3.66+0.10(+2.81%)
Day's Range
3.473.59
52 wk Range
3.3011.04
Prev. Close
3.56
Open
3.56
Day's Range
3.47-3.59
52 wk Range
3.3-11.04
Volume
978,383
Average Vol. (3m)
1,299,017
1-Year Change
-65.87%
Shares Outstanding
57,531,999
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
4.25
Upside +19.38%

People Also Watch

52.00
FMC
-2.05%
11.800
PTEN
-1.42%
87.94
PHM
-0.18%
113.84
ZBH
+0.36%
122.72
EL
-0.96%
How do you feel today about VNDA?
Vote to see community's results!
or

Vanda Pharmaceuticals Inc Company Profile

Vanda Pharmaceuticals Inc. (Vanda) is a global biopharmaceutical company focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Vanda's commercial portfolio is comprised of two products, HETLIOZ for the treatment of jet lag disorder, insomnia, delayed sleep phase disorder (DSPD), sleep disturbances in autism spectrum disorder (ASD) and pediatric Non-24 and Fanapt for the treatment of bipolar I disorder and Parkinsons disease psychosis and a long acting injectable (LAI) formulation for the treatment of schizophrenia. In addition, the Company has a range of drugs in development, including Tradipitant (VLY-686), for the treatment of gastroparesis, motion sickness, atopic dermatitis, and Covid-19 pneumonia; VTR-297 for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications, and VQW-765, for the treatment of performance anxiety and psychiatric disorders.